Companies: 10,795·Total market cap: $144.5T
Genmab A/S

Genmab A/S

GMABNASDAQHealthcare● Active
$25.15
+$0.42(+1.70%)
Market Cap$15.4B
P/E Ratio—
52W High$35.43
52W Low$20.225
Net IncomeFinancialsRevenue

Genmab A/S (GMAB) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

GMAB · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $963.8M for FY2025 (fiscal year ending 2025-12-31), down 87.7% year-over-year. Net profit margin was 25.9%. Based on available data, Genmab A/S has been profitable since at least 2013.

FY2025 Net Income$963.8M▼ -87.7% YoY
Trailing 12M (TTM)$821.0Mtrailing 4 quarters sum
Net Profit Margin25.9%$963.8M ÷ $3.72B
YoY Change-87.7%—
5-Year CAGR-27.3%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2013

▸ FMP /income-statement · Annual · GMAB net income history · GMAB profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$963.8M▼ 87.7%25.9%
FY2024$7.84B▲ +80.2%36.4%
FY2023$4.35B▼ 20.2%26.4%
FY2022$5.45B▲ +84.4%37.6%
FY2021$2.96B▼ 37.9%35.1%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Genmab A/S
Genmab A/SYOU
GMAB
$963.8M-87.7%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Genmab A/S (GMAB) reported net income of $963.8M for FY2025 (fiscal year ending 2025-12-31), down 87.7% year-over-year. The net profit margin was 25.9% — meaning the company kept $0.26 of every dollar of revenue as profit.

Based on available data, Genmab A/S has been profitable since at least 2013. Net income reached a peak of $7.84B in FY2024. Data available for 15 fiscal years.

Genmab A/S's net profit margin was 25.9% for FY2025, based on the latest annual results.

Investors sometimes search for "Genmab A/S net worth" — the company's market capitalization is a separate figure from GMAB net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.
RevenueFinancial statementsEarningsForecastPrice historyMarket capFree cash flow

Frequently asked questions

GMAB net income · 5 questions

Genmab A/S is profitable. The company reported net income of $963.8M for FY2025, a net profit margin of 25.9%. Net income was down 87.7% year-over-year. Based on available data, Genmab A/S has been profitable since at least 2013.

is GMAB profitabledoes GMAB make a profitGMAB profitabilityGMAB profitable company

▸ Source: FMP /income-statement · GAAP · Genmab A/S · Genmab A/S SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026